Molecular mechanisms and pathogenesis of MASH

AI Insight

This review article examines the current understanding of molecular and cellular mechanisms that drive the development of metabolic dysfunction-associated steatohepatitis (MASH), a liver disease characterized by inflammation and fat accumulation. The authors analyze the pathogenic processes that lead to MASH progression and its potential transformation into hepatocellular carcinoma, the most common type of primary liver cancer.

Why it matters

Understanding the mechanistic pathways of MASH progression to liver cancer is critical for developing targeted therapeutic interventions, as MASH prevalence is rising globally alongside metabolic syndrome and obesity. This knowledge could inform early detection strategies and treatment approaches for patients at risk of developing liver cancer from metabolic liver disease.